In breast cancer, the VEGFA expression is positivity significantly correlated with PD-L1, and VEGFA may be a predictor of immune characteristics and serves as a useful biomarker for immune targeted therapy (Fujii et al. 2020). This evidence concerns the gene VEGFA and breast cancer.